E. Sparve

Human exposure to triclosan via toothpaste does not change CYP3A4 activity or plasma concentrations of thyroid hormones.

G. Sandborgh-Englund, G. Panagiotidis, U. Diczfalusy, 2009, Basic & clinical pharmacology & toxicology.

Prediction and Modeling of Effects on the QTc Interval for Clinical Safety Margin Assessment, Based on Single-Ascending-Dose Study Data with AZD3839

Michael D B Swedberg, C. Pollard, M. Bridgland-Taylor, 2014, The Journal of Pharmacology and Experimental Therapeutics.

A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout Flares

R. Terkeltaub, K. Saag, S. Ohlman, 2021, Arthritis & rheumatology.

A simple validated multi-analyte method for detecting drugs in oral fluid by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).

Yufang Zheng, E. Sparve, Mats Bergström, 2018, Drug testing and analysis.

Cytochrome P450 Induction by Rifampicin in Healthy Subjects: Determination Using the Karolinska Cocktail and the Endogenous CYP3A4 Marker 4β‐Hydroxycholesterol

L. Bertilsson, U. Diczfalusy, E. Sparve, 2008, Clinical pharmacology and therapeutics.

Detection of drugs in oral fluid samples using a commercially available collection device: agreement with urine testing and evaluation of A and B samples obtained from employees at different workplace settings with uncontrolled sampling procedures.

Yufang Zheng, E. Sparve, Mats Bergström, 2020, Journal of analytical toxicology.

Acute clozapine intoxication.

P. Nordberg, S. Forsberg, E. Sparve, 2009, Journal of clinical psychopharmacology.

Long-term safety and outcomes in hereditary tyrosinaemia type 1 with nitisinone treatment: a 15-year non-interventional, multicentre study.

M. Couce, C. Dionisi-Vici, A. Lund, 2021, The lancet. Diabetes & endocrinology.

CLINICAL STUDIES OF CYP 3 A 4 AND P-GLYCOPROTEIN

L. Bertilsson, G. Panagiotidis, E. Sparve, 2016 .

Population pharmacokinetic and pharmacodynamic analysis of plasma Aβ40 and Aβ42 following single oral doses of the BACE1 inhibitor AZD3839 to healthy volunteers

Chi-Ming Lee, E. Sparve, J. Fälting, 2014, Clinical pharmacology in drug development.